Romin Nabiey - 08 Dec 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Signature
/s/ Gracye Cheng, Attorney-in-Fact for Romin Nabiey
Issuer symbol
GDRX
Transactions as of
08 Dec 2025
Net transactions value
-$12,057
Form type
4
Filing time
08 Dec 2025, 18:28:04 UTC
Previous filing
17 Nov 2025
Next filing
09 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nabiey Romin Chief Accounting Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA /s/ Gracye Cheng, Attorney-in-Fact for Romin Nabiey 08 Dec 2025 0001924892

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +10,200 +6.5% 167,692 08 Dec 2025 Direct F1
transaction GDRX Class A Common Stock Tax liability $9,892 -3,650 -2.2% $2.71 164,042 08 Dec 2025 Direct
transaction GDRX Class A Common Stock Options Exercise +2,232 +1.4% 166,274 08 Dec 2025 Direct F1
transaction GDRX Class A Common Stock Tax liability $2,165 -799 -0.48% $2.71 165,475 08 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -10,200 -25% $0.000000 30,603 08 Dec 2025 Class A Common Stock 10,200 Direct F1, F2
transaction GDRX Restricted Stock Unit Options Exercise $0 -2,232 -10% $0.000000 20,091 08 Dec 2025 Class A Common Stock 2,232 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
F3 The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.